Companies: 10,795·Total market cap: $144.5T
IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc.

IDXXNASDAQHealthcare● Active
$562.87
+$0.71(+0.13%)
Market Cap$44.4B
P/E Ratio
52W High$769.98
52W Low$506.91
Overview

IDEXX Laboratories, Inc. (IDXX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · IDXX · as of Jun 8, 2026

Key Statistics

EPS (TTM)$13.67idxx eps ttm · idxx earnings per shareEarnings history
PE Ratio (TTM)41.2×idxx pe ratio ttm · idxx price to earningsPE Ratio deep dive
Revenue (TTM)$4.4Bidxx revenue ttm · idxx annual revenueFull revenue history
Dividend YieldNo Dividenddoes idxx pay dividends · idxx dividend yieldDividend history
Shares Outstanding80.1Midxx shares outstanding · idxx floatShares outstanding history
Next EarningsAug 3, 2026Est.idxx earnings date · idxx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$4.30B▲ +10.42% YoY
202320242025
idexx laboratories, inc. revenue · idxx revenue 2025
FY 2025Net Income$1.06B▲ +19.33% YoY
202320242025
idexx laboratories, inc. net income · idxx profit 2025
FY 2025EPS$13.17▲ +22.28% YoY
202320242025
idxx eps · idexx laboratories, inc. earnings per share 2025
TTM:Revenue: $4.45BNet Income: $1.10BEPS: $13.67View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy22 analystsis idxx a buy · idxx analyst rating
Strong Buy
0
Buy
13
Hold
8
Sell
1
Strong Sell
0
12-Month Price Target
$640.00Low
$562.87Current
$747.50Avg Target32.80% upside
$800.00High
idxx price target · idxx 12 month forecast

Total: 22 · Buy rate: 59.1%

The IDXX analyst consensus is Buy, based on ratings from 22 Wall Street analysts over the past 3 months. The average 12-month price target is $747.50, representing +32.80% upside from the current price of $562.87.

Stock Performance

Full History
1D+0.17%
1W+2.49%
1M+0.53%
3M-7.45%
YTD-16.77%
1Y+8.58%
5Y+0.32%

About IDEXX Laboratories, Inc.

CEOJonathan J. Mazelsky
IPO DateJun 21, 1991
Employees11,000
CountryUS
Websiteidexx.com

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide.…

what is idexx laboratories, inc. · idxx stock overview · idexx laboratories, inc. company profile · who is idexx laboratories, inc. ceo · idxx NASDAQ · idexx laboratories, inc. headquarters · idexx laboratories, inc. business segments

About Stock Overview & Key Data

IDEXX Laboratories, Inc. (IDXX) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Jun 21, 1991. As of the latest trading session, IDXX stock price is $562.87, with a market capitalization of $44.4B. The stock has returned +8.58% over the past 12 months and -16.77% year-to-date.

According to 22 Wall Street analysts, the consensus rating for IDEXX Laboratories, Inc. stock is Buy, with an average 12-month price target of $747.50. In fiscal year 2025, IDEXX Laboratories, Inc. reported revenue of $4.3B and net income of $1.1B. For detailed data — including IDEXX Laboratories, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, IDEXX Laboratories, Inc. (IDXX) stock price is $562.87. The stock is traded on NASDAQ under the ticker symbol IDXX. The 52-week range is $506.91 – $769.98.

IDXX stock priceIDXX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice